The Kaplan-Meier (KM) plot revealed a shorter overall survival (OS) and disease-specific survival (DSS) of ccRCC patients with high OCT4 or Nanog expression than patients with low OCT4 or Nanog expression (Fig. 4F and Supplementary Fig. 7). This evidence concerns the gene NANOG and nonpapillary renal cell carcinoma.